Gene · 1301
Papers2,518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,518
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Crosstalk between cancer-associated fibroblasts and tumor cells in the tumor microenvironment: an emerging target of anti-cancer immunotherapy. | Front Pharmacol | 2023 | 37601054 | PubTator, text mining | PubMed |
| Pancancer network analysis reveals key master regulators for cancer invasiveness. | J Transl Med | 2023 | 37599366 | PubTator, text mining | PubMed |
| Preliminary investigation of elevated collagen and blood-clotting markers as potential noninvasive biomarkers for small cell lung cancer. | Thorac Cancer | 2023 | 37596821 | PubTator, text mining | PubMed |
| Bioengineered human tissue regeneration and repair using endogenous stem cells. | Cell Rep Med | 2023 | 37586324 | PubTator, text mining | PubMed |
| Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial. | Nat Commun | 2023 | 37580352 | PubTator, text mining | PubMed |
| Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups. | Ann Rheum Dis | 2023 | 37580109 | PubTator, text mining | PubMed |
| Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2023 | 37577214 | PubTator, text mining | PubMed |
| Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer. | Cancer Res Commun | 2023 | 37575280 | PubTator, text mining | PubMed |
| Androgen receptor suppresses lung cancer invasion and increases cisplatin response via decreasing TPD52 expression. | Int J Biol Sci | 2023 | 37564195 | PubTator, text mining | PubMed |
| Analysis of children with familial short stature: who should be indicated for genetic testing? | Endocr Connect | 2023 | 37561071 | PubTator, text mining | PubMed |
| New insights into the role of adipocytes in pancreatic cancer progression: paving the way towards novel therapeutic targets. | Theranostics | 2023 | 37554282 | PubTator, text mining | PubMed |
| SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling. | Front Immunol | 2023 | 37545510 | PubTator, text mining | PubMed |
| TMT-based quantitative proteomic analysis revealed that FBLN2 and NPR3 are involved in the early osteogenic differentiation of mesenchymal stem cells (MSCs). | Aging (Albany NY) | 2023 | 37543430 | PubTator, text mining | PubMed |
| Total RNA sequencing reveals gene expression and microbial alterations shared by oral pre-malignant lesions and cancer. | Hum Genomics | 2023 | 37542347 | PubTator, text mining | PubMed |
| Lysyl oxidase-like 1-antisense 1 (LOXL1-AS1) lncRNA differentially regulates gene and protein expression, signaling and morphology of human ocular cells. | Hum Mol Genet | 2023 | 37540217 | PubTator, text mining | PubMed |
| Single-cell transcriptomics of human cholesteatoma identifies an activin A-producing osteoclastogenic fibroblast subset inducing bone destruction. | Nat Commun | 2023 | 37537159 | PubTator, text mining | PubMed |
| Identification of genes critical for inducing ulcerative colitis and exploring their tumorigenic potential in human colorectal carcinoma. | PLoS One | 2023 | 37535606 | PubTator, text mining | PubMed |
| Integrative analysis of transcriptome dynamics during human craniofacial development identifies candidate disease genes. | Nat Commun | 2023 | 37532691 | PubTator, text mining | PubMed |
| Chondrocyte Homeostasis and Differentiation: Transcriptional Control and Signaling in Healthy and Osteoarthritic Conditions. | Life (Basel) | 2023 | 37511835 | PubTator, text mining | PubMed |
| The Role of Genetics and Epigenetic Regulation in the Pathogenesis of Osteoarthritis. | Int J Mol Sci | 2023 | 37511413 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1301/papers?page=18